Comparative Bioavailability in Healthy Elderly Volunteers
Comparative Bioavailability of TRx0037 and TRx0014 in Healthy Elderly Volunteers
Sponsor: Quotient Clinical
A PHASE1 clinical study on Alzheimer's Disease, this trial is completed. The trial is conducted by Quotient Clinical and has accumulated 4 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE1
First recorded
Feb 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Quotient Clinical
- TauRx Therapeutics Ltd
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.